Institutional shares held 810,273
0 calls
0 puts
Total value of holdings $5.89M
$0 calls
$0 puts
Market Cap $257M
33,775,100 Shares Out.
Institutional ownership 2.4%
# of Institutions 24


Latest Institutional Activity in INKT

Top Purchases

Q4 2024
Tower Research Capital LLC (Trc) Shares Held: 5.4K ($41.1K)
Q4 2024
Northern Trust Corp Shares Held: 11.4K ($87.1K)
Q4 2024
Jpmorgan Chase & CO Shares Held: 325 ($2.47K)
Q4 2024
Concourse Financial Group Securities, Inc. Shares Held: 0 ($0)
Q3 2024
Two Sigma Securities, LLC Shares Held: 11.9K ($90.8K)

Top Sells

Q4 2024
Renaissance Technologies LLC Shares Held: 102K ($774K)
Q4 2024
Ubs Group Ag Shares Held: 2.85K ($21.7K)
Q4 2024
Geode Capital Management, LLC Shares Held: 96.1K ($731K)
Q4 2024
High Tower Advisors, LLC Shares Held: 50.7K ($386K)
Q4 2024
Wells Fargo & Company Shares Held: 10.1K ($76.7K)

About INKT

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York. MiNK Therapeutics, Inc. operates as a subsidiary of Agenus Inc.


Insider Transactions at INKT

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
258K Shares
From 5 Insiders
Grant, award, or other acquisition 258K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on INKT

Follow MiNK Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if
Any

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT